Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
QuidelOrtho
AddedMar 19, 2024
UpdatedJun 18, 2026
QuidelOrtho

QuidelOrtho

Public

Leading San Diego medical manufacturer of global diagnostic products.

HQ
San Diego, CA, US
Founded
2021
Overview
Compare
Employees
Website

QuidelOrtho Corporation, founded through the merger of Quidel Corporation and Ortho Clinical Diagnostics, focuses on enhancing healthcare through innovative diagnostic solutions. The company's core mission is to improve patient outcomes by providing advanced diagnostic technologies. QuidelOrtho offers a wide range of products and services, including clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening, and point-of-care diagnostics. Their market focus spans across hospitals, laboratories, and clinics globally.

Notable figures associated with QuidelOrtho include key executives from both legacy companies who have extensive experience in the diagnostics industry. The company has received significant investment from leading healthcare investors. Key achievements include the development of cutting-edge diagnostic platforms that have significantly improved disease detection and management. QuidelOrtho's impact is evident in its contribution to more accurate and timely diagnostics, thereby enhancing patient care worldwide.

QuidelOrtho - Quick Facts

When was QuidelOrtho founded?

QuidelOrtho was founded in 2021.

Where is QuidelOrtho's headquarters located?

QuidelOrtho's headquarters is located in San Diego, CA, US.

How many employees does QuidelOrtho have?

QuidelOrtho has 7,000 employees as of Feb 6, 2024.

QuidelOrtho - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Diagnostics
Geographic Exposure
  • Global
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostics
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
Unique IDs
  • secCik: 0001906324
  • ticker: QDEL
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325413In-Vitro Diagnostic Substance Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 3900Miscellaneous Manufacturing Industries
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 5040Professional And Commercial Equipment And Supplies
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8731Commercial Physical and Biological Research